Alumis Inc. Common Stock

Alumis Inc. Common Stockverified

ALMS

Price:

$8.3

Market Cap:

$866.53M

Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. It develops ESK-001, an allosteric tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis, systemic lupus erythematosus, and non-infectious uveitis; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor for neuroinflammatory and neurodegenerative diseases. The company was formerly known as Esker Therapeutics, Inc. and changed its name to Alumis Inc. in January 2022. The company was incorporated in 2021 and is headquartered in South San Francisco, California.

Industry

Biotechnology

IPO Date

2021-02-22

Stock Exchange

NASDAQ

Ticker

ALMS

The PE Ratio as of December 2025 (TTM) for Alumis Inc. Common Stock (ALMS) is -3.86

According to Alumis Inc. Common Stock’s latest financial reports and current stock price. The company's current PE Ratio is -3.86. This represents a change of 130.80% compared to the average of -1.67 of the last 4 quarters.

Alumis Inc. Common Stock (ALMS) Historical PE Ratio (quarterly & annually)

How has ALMS PE Ratio performed in the past?

The mean historical PE Ratio of Alumis Inc. Common Stock over the last ten years is -2.03. The current -3.86 PE Ratio has changed 18.89% with respect to the historical average. Over the past ten years (40 quarters), ALMS's PE Ratio was at its highest in in the June 2025 quarter at 0.97. The PE Ratio was at its lowest in in the December 2024 quarter at -5.88.

Quarterly (TTM)
Annual

Average

-2.03

Median

-0.89

Minimum

-4.45

Maximum

-0.76

Alumis Inc. Common Stock (ALMS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Alumis Inc. Common Stock PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 399.36%

Maximum Annual PE Ratio = -0.76

Minimum Annual Increase = -82.98%

Minimum Annual PE Ratio = -4.45

Quarterly (TTM)
Annual
YearPE RatioChange
2024-0.76-82.98%
2023-4.45399.36%

Alumis Inc. Common Stock (ALMS) Average PE Ratio

How has ALMS PE Ratio performed in the past?

The current PE Ratio of Alumis Inc. Common Stock (ALMS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-2.03

5-year avg

-2.03

10-year avg

-2.03

Alumis Inc. Common Stock (ALMS) PE Ratio vs. Peers

How is ALMS’s PE Ratio compared to its peers?

Alumis Inc. Common Stock’s PE Ratio is greater than RAPT Therapeutics, Inc. (-8.80), less than Neumora Therapeutics, Inc. Common Stock (-1.56), less than ADC Therapeutics S.A. (-2.89), greater than Ocugen, Inc. (-6.36), greater than Eton Pharmaceuticals, Inc. (-67.66), greater than Omeros Corporation (-6.03), greater than Fulcrum Therapeutics, Inc. (-7.71), greater than Lexicon Pharmaceuticals, Inc. (-4.28), less than Bicycle Therapeutics plc (-1.97), greater than Lineage Cell Therapeutics, Inc. (-5.89),

Build a custom stock screener for Alumis Inc. Common Stock (ALMS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alumis Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alumis Inc. Common Stock (ALMS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alumis Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Alumis Inc. Common Stock's PE Ratio?

How is the PE Ratio calculated for Alumis Inc. Common Stock (ALMS)?

What is the highest PE Ratio for Alumis Inc. Common Stock (ALMS)?

What is the 3-year average PE Ratio for Alumis Inc. Common Stock (ALMS)?

What is the 5-year average PE Ratio for Alumis Inc. Common Stock (ALMS)?

How does the current PE Ratio for Alumis Inc. Common Stock (ALMS) compare to its historical average?